Genovis AB (FRA:5GV) Beginning Cash Position: €15.59 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5GV Genovis AB FRA:5GV
94 GF Score
Price €1.75
GF Value €2.21
! 2 Warning Signs
View Full Analysis

What is Genovis AB Beginning Cash Position?

Genovis AB FRA:5GV +2.10% 94 Beginning Cash Position is €15.59 Mil as of Jun. 2026. GuruFocus rates FRA:5GV with a GF Score™ of 94/100 and a GF Value™ of €2.21. The stock has 2 warning signs investors should review.

Genovis AB's Beginning Cash Position for the quarter that ended in Jun. 2026 was €15.59 Mil.

Genovis AB's quarterly Beginning Cash Position increased from Dec. 2025 (€14.23 Mil) to Mar. 2026 (€15.15 Mil) and increased from Mar. 2026 (€15.15 Mil) to Jun. 2026 (€15.59 Mil).

Genovis AB's annual Beginning Cash Position increased from Dec. 2023 (€6.51 Mil) to Dec. 2024 (€10.72 Mil) and increased from Dec. 2024 (€10.72 Mil) to Dec. 2025 (€15.57 Mil).

Genovis AB Beginning Cash Position Related Terms

Genovis AB Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Genovis AB's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genovis AB Beginning Cash Position Chart

Genovis AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.30 7.40 6.51 10.72 15.57

Genovis AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.93 15.36 14.23 15.15 15.59
FRA:5GV
94GF Score
Genovis AB FRA:5GV
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genovis AB Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of €15.59 Mil mean?
Genovis AB (FRA:5GV) has a Beginning Cash Position of €15.59 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Genovis AB and its competitors.
Is Genovis AB's Beginning Cash Position too high?
Genovis AB's current Beginning Cash Position is €15.59 Mil. Overall, Genovis AB has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does Genovis AB's Beginning Cash Position compare to VRTX and REGN?
Genovis AB's Beginning Cash Position of €15.59 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Genovis AB and its competitors. Genovis AB's current Beginning Cash Position is €15.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genovis AB stock overvalued right now?
Genovis AB (FRA:5GV) has a current Beginning Cash Position of €15.59 Mil. The stock's GF Value™ is €2.21, compared to a current price of €1.75 — trading 20.9% below its estimated fair value. The current Beginning Cash Position is €15.59 Mil. Genovis AB's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Genovis AB (FRA:5GV), the current Beginning Cash Position is €15.59 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genovis AB (FRA:5GV) Overvalued in 2026?

Based on GuruFocus' analysis, Genovis AB stock appears to be undervalued. The current stock price of €1.75 is trading 20.9% below its estimated GF Value™ of €2.21.

Key valuation signals for FRA:5GV:

  • Beginning Cash Position: €15.59 Mil
  • GF Value™: €2.21 vs. price of €1.75 (20.9% below fair value)
  • GF Score™: 94/100 with 2 warning signs

No single metric tells the full story. See the FRA:5GV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genovis AB Business Description

Other Exchanges GENO:Sweden
Address Kavlinge, Box 4, Lund, SWE, SE-24421
Genovis AB offers customers in the biopharmaceutical and research industries tools that facilitate and save time in the development of new treatment methods and diagnostics. Its enzyme products, known as SmartEnzymes, are used by scientists all over the world, and the product formats facilitate the development and quality control of biological drugs. Its products include Enzyme and Antibodies. Geographically, it operates in Sweden and Rest of the world.
94GF Score

Get the complete analysis for FRA:5GV

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.75
Price
€2.21
GF Value